• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Arterioscler Thromb Vasc Biol. Author manuscript; available in PMC Dec 1, 2010.
Published in final edited form as:
PMCID: PMC2796372
NIHMSID: NIHMS153698

Absence of Akt1 reduces vascular smooth muscle cell migration and survival and induces features of plaque vulnerability and cardiac dysfunction during atherosclerosis

Abstract

Objective

Deletion of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. VSMC are an important component of atherosclerotic plaques, responsible for promoting plaque stability in advanced lesions. Fibrous caps of unstable plaques contain less collagen and ECM components and fewer VSMCs than caps from stable lesions. Here, we investigated the role of Akt1 in VSMC proliferation, migration and oxidative stress-induce apoptosis. In addition, we also characterized the atherosclerotic plaque morphology and cardiac function in an atherosclerosis-prone mouse model deficient in Akt1.

Methods and Results

Absence of Akt1 reduces VSMC proliferation and migration. Mechanistically, the proliferation and migratory phenotype found in Akt1 null VSMCs was linked to reduced Rac-1 activity and MMP-2 secretion. Serum starvation and stress-induced apoptosis was enhanced in Akt1 null VSMCs as determined by flow cytometry using Annexin V/PI staining. Immunohistochemical analysis of atherosclerotic plaques from Akt1−/−ApoE−/− mice showed a dramatic increase in plaque vulnerability characteristics such as enlarged necrotic core and reduced fibrous cap and collagen content. Finally, we show evidences of myocardial infarcts and cardiac dysfunction in Akt1−/−ApoE−/− mice analyzed by immunohistochemistry and echocardiography respectively.

Conclusion

Akt1 is essential for VSMC proliferation, migration and protection against oxidative stress-induce apoptosis. Absence of Akt1 induces features of plaque vulnerability and cardiac dysfunction in a mouse model of atherosclerosis.

Keywords: Akt1, atherosclerosis, apoptosis susceptibility, cell migration, and cardiac dysfunction

INTRODUCTION

Atherosclerosis is a progressive disease characterized by the accumulation of lipids and fibrous elements in the large arteries 13. This complex disease involves interactions of modified lipoproteins, monocyte-derived macrophages or foam cells, T-lymphocytes, endothelial cells (ECs), vascular smooth muscle cells (VSMCs), and fibroblast 4, 5. VSMCs are an important component of atherosclerotic plaques, responsible for promoting plaque stability in advanced lesions 4. The structural components of atherosclerotic plaque caps consist primarily of VSMC-derived collagen, elastin, proteoglycans and extracellular matrix (ECM) 4, 5. Fibrous caps of unstable plaques contain less collagen and ECM components and fewer VSMCs than caps from stable lesions. Apoptosis of VSMCs may lead to atherosclerotic plaque instability and rupture, resulting in myocardial infarction, stroke, and sudden death 6, 7.

The serine/threonine kinase Akt (also known as protein kinase B [PKB]) plays a central role in the regulation of cellular growth, survival and metabolism 8, 9. In mammalian cells, there are three distinct Akt isoforms (Akt1,-2, and -3) which are products of different genes 10. Gene knockout studies have shown that despite significant sequence homology, the three Akt isoforms have some non redundant functions. In the cardiovascular system, Akt1 plays an important role in the regulation of cardiac hypertrophy, angiogenesis, and apoptosis 1113. More importantly, we have recently reported that absence of Akt1 leads to severe atherosclerosis and occlusive artery disease 14. The increased atherosclerosis observed in mice lacking Akt1 is mechanistically linked to endothelial cell dysfunction. However, the role of Akt1 in VSMC biology and its implication in the progression of atherosclerosis remain unknown. Here, we report that Akt1 is essential for VSMC proliferation, migration and protection against oxidative stress-induce apoptosis. Moreover, we show that absence of Akt1 in atherosclerosis-prone apolipoprotein E (ApoE) knockout mice induce features of plaque vulnerability such as increased necrotic core formation and reduced fibrous cap. Finally, we show evidences of spontaneous infarcts in mice lacking Akt1, a rare phenotype observed in murine models of atherosclerosis. The presence of infarcts in Akt1−/−ApoE−/− mice provides a new model for studying atherosclerosis-induce coronary syndromes in mice.

MATERIALS AND METHODS

Animal procedures

Akt1−/− mice were generated as previously described 15. Akt1−/− mice that have been backcrossed 6 generations onto a C57BL/6 background were crossed with ApoE-deficient mice, also on the C57BL/6 background, to generate mice heterozygous at both loci. These ApoE+/− Akt1−/− mice were crossed a second time with ApoE−/− mice. The ApoE−/− Akt1−/+ progeny from this round of breeding were then inter-crossed to produce ApoE−/− Akt1−/− and ApoE−/− Akt1+/+ littermates that were used as controls for all studies. Accelerated atherosclerosis was induced by feeding the mice for 14 weeks with a high-fat Western-type diet containing 1.25% cholesterol (ResearchDiets, D12108). All animal protocols were approved by the Institutional Animal Care Use Committee of Yale University.

Atherosclerotic lesion analysis

After 12 weeks of being fed a Western-type diet, male mice (7 ApoE−/− Akt1+/+ and 6 ApoE−/− Akt1−/−) were anesthetized and euthanized. Mouse hearts were perfused using 10 ml of PBS (Invitrogen) followed by 10 ml of 4% paraformaldehyde (PFA). After overnight incubation in 4% PFA, washed tissues were embedded in OCT blocks. The proximal aorta was cut in 10 µm thick cryosections and stained with hematoxylin/eosin and Masson’s trichrome. Images were captured with an Eclipse 80i microscope (Nikon), DMX 1200C digital camera (Nikon) using NIS-elements D 3.0 and analyzed using Image J software (NIH). Fibrous caps were defined as the VSMC and proteoglycan-rich area overlying the cholesterol-rich, matrix-poor, acellular regions of the necrotic cores.

Primary aortic smooth muscle cells isolation and culture

Mouse primary VSMC were isolated from normal aorta of male mice by combined collagenase and elastase digestion method. Cells were cultured in DMEM containing 10% fetal bovine serum (FBS) and used until 10 passages. Human aortic VSMCs were isolated by explant outgrowth and serially cultured in M199 medium supplemented with 20% FBS, L-glutamine, and antibiotics. Human VSMCs were used at passages 3 and 4.

VSMCs proliferation assay

VSMC were grown in DMEM medium supplemented with 10% of FBS. At the indicated times, viable cells were determined by Trypan blue dye exclusion using a hemocytometer.

VSMC migration assay

Transwell inserts (Costar transwell inserts; Corning) were coated with 0.1% gelatin (Sigma). Platelet-derived growth factor (PDGF) at 1 and 10 ng/ml dissolved in DMEM medium containing 0.1% FBS was added in the bottom chamber. VSMCs (5×104 cells per well) suspended in 100 µl of DMEM containing 0.1% BSA was added to the upper chamber. After 5 hours of incubation, cells on both side of the membrane were fixed and stained with Diff-Quick staining kit (Baxter Healthcare Corp). Cells on the upper side of the membrane were removed with a cotton swab. The average number of cells from five randomly chosen high power (200X) fields on the lower side of the membrane was counted.

Phalloidin staining

Cells were fixed with 2% formaldehyde and permeabilized with 0.1% Triton X-100 in phosphate buffered saline, pH 7.5. F-actin was examined using Alexa 568-conjugated phalloidin (Invitrogen).

Rac activity assay

Pull-down of GTP-bound Rac was performed by incubating cell lysates with GST-fusion protein containing the p21-binding domain of PAK-1 bound to glutathione agarose for 1 hour at 4°C. The amount of GTP-bound Rac was examined by immunoblotting using a Rac monoclonal antibody (BD Transduction Laboratories).

Flow cytometry analysis of apoptotic cells

Apoptotic cells were determined by their hypochromic, subdiploid staining profiles (SubG1 population). VSMCs cultured in absence of serum or in presence of different doses of hydrogen peroxide (H2O2) were stained with propidium iodide (PI) and analyzed by flow cytometry (FACSort, Becton Dickinson). For staining, one million cells were harvested, washed in PBS, and then fixed with ethanol 70% ethanol. Fixed cells were treated with DNase-free (Roche) for 30 min at 37°C, washed in PBS, centrifuged, and incubated in PBS containing PI (25 µg/ml; Sigma). Forward light scatter characteristics were used to exclude cell debris from the analysis. For the estimation of early apoptotic cells, Alexa fluorescein isothiocyanate (FITC)-conjugated annexin V (Molecular Probes) was used together with PI dead cell counterstain according to the manufacturer’s recommendations.

Western blot analysis

VSMCs were resuspended in lysis buffer: 50 mM Tris-HCl, pH 7.4, 0.1 mM EDTA, 0.1 mM EGTA, 1% NP-40, 0,1% sodium deoxycholate, 0,1% SDS, 100 mM NaCl, 10 mM NaF, 1 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 1 mM Pefabloc SC, and 2 mg/ml protease inhibitor cocktail (Roche Diagnostics Corp). Protein concentrations were determined using the DC Protein assay kit (Bio-Rad Laboratories). Lysates containing 30 µg of protein were analyzed by SDS-PAGE and immunoblotting. Primary antibodies used include the following: Akt, p-Akt473, p-Akt308, Akt1, p-FoxO1, FoxO1, p-GSK3, GSK3, p-MDM2, MDM2, ERK, p-ERK, p38 MAPK, p-p38 MAPK (Cell Signaling), PDGFR, Hsp90 (BD Transduction Laboratories; BD Biosciences-Pharmingen). Secondary antibodies were fluorescence-labeled antibodies (LI-COR Biotechnology). Bands were visualized using the Odyssey Infrared Imaging System (LI-COR Biotechnology).

Zymography

Aliquots of cell lysates and conditioned media were analyzed on a 0.1% gelatin-10% zymogram. Cells were lysed in SDS-sample buffer. Appropriately diluted media and cell lysate were loaded without reduction on gels at 10 ul and at an equivalent of 2,5 ug proteins per lane, respectively. After electrophoresis, gels were washed with enzyme renaturing buffer (2.5% TritonX100 in 50 mM tris pH 7.4, 5 mM CaCl2, 1 microM ZnCl2) and incubated in developing buffer (50 mM Tris pH 7.4, 5 mM CaCl, 1 microM ZnCl2) overnight at 37°C. The gel was then stained with Coomassie blue (25% methanol, 15% acetic acid, 0.1% Coomassie blue) for 1 h at room temperature, and destained in 25% methanol/15% acetic acid for at least 2 h with multiple changes of destaining solution. The different MMPs were identified by size.

Echocardiography

Mice from different groups were anesthetized with isoflurane (0.2 % in O2) and subjected to transthoracic echocardiography with a Vevo770 (VisualSonics) ecocardiograph (Perrino C et al 2006). In brief, left ventricular (LV) M-mode echocardiography was performed (VisualSonics). All measurements were made in three to six consecutive cardiac cycles, and the averaged values used for analysis. LV end-diastolic (LVDd) and end-systolic (LVDs) dimensions as well as the thickness of the interventricular septum (IVST) and posterior wall (PWT) were measured from the M-mode tracings, and fractional shortening (FS) was calculated as (LVDd − LVDs)/LVDd . Diastolic measurements were performed at the point of greatest cavity dimension, and systolic measurements were made at the point of minimal cavity dimension, using the leading-edge method of the American Society of Echocardiography 16.

TTC staining

After sectioning, slides were immediately immersed in 2% of 2,3,5-Triphenyltetrazolium chloride (TTC, Sigma-Aldrich) in 0.9% NaCl at 37°C for 10 min, photographed and transferred in 4% PFA.

Statistical analysis

Data are presented as mean ± SEM (n is noted in the figure legends). Comparison of mean values between groups was evaluated by 2-tailed Student’s t-test and Mann-Whitney U test. A P value of less than 0.05 was considered significant.

RESULTS

Absence of Akt1 decreased VSMC proliferation and migration

VSMC migration and proliferation are critical at different stages of atherosclerosis progression 1. To investigate whether Akt1 is important for regulating proliferation and migration, we analysed VSMC proliferation at different time points and cell migration using a transwell assay. As shown in Fig. 1a, VSMCs isolated from Akt1−/− mice did not grow as well as cells isolated from WT mice. Next, we examined the role of Akt1 in VSMC migration in response to either FBS or PDGF. As shown in Fig. 1b the absence of Akt1 reduces FBS and PDGF-induced migration of VSMC. Furthermore, the reintroduction of Akt1, but not GFP (by retrovirus) into Akt1−/− VSMCs rescued the defective migratory phenotype in response to serum and PDGF (Fig. 1c). Similar results were obtained using human aortic VSMC after silencing Akt1 with siRNA (Fig. 1d).

Figure 1
Absence of Akt1 reduces VSMC proliferation and migration

Akt1 is necessary for PDGF-mediated dorsal ruffle formation, Rac activation and MMP-2 activity in VSMCs

Formations of lamellipodia and membrane ruffles at the leading edge are early events regulating directional cell migration. Since Akt1 has been shown to be important for cell spreading and directional migration in EC and fibroblast 17, we determined whether Akt1 is necessary for VSMC dorsal ruffle formation in response to PDGF. As shown in Fig. 2a, and quantified in the right panel, VSMC lacking Akt1 exhibit a significant reduction in dorsal ruffle formation after PDGF treatment. Previous studies in fibroblast and ECs have also demonstrated that Akt1 activity is necessary for Rac1-Pac signalling 17. As seen in Fig. 2b, absence of Akt1 significantly reduces Rac1 activity (assayed as Rac1-GTP) after PDGF stimulation. Matrix metalloproteinase-2 (MMP-2) is known to play several important roles during changes is vascular structure associated with both normal and disease processes. The stimulation of VSMC with PDGF leads to increased expression of MMP-2 18 and this up-regulation was linked to increased cell migration 18, 19. PDGF-induced MMP-2 has been shown to be dependent on the action of phosphatidylinositol 3-kinase (PI3K) and its downstream effector, Akt 20. To test whether Akt1 is necessary for MMP-2 expression, we stimulated VSMC with PDGF and analysed the metalloproteinase activity by zymography. As seen in Fig. 2c, and quantified in the right panel, PDGF weakly induced MMP-2, but cells lacking Akt1 had a marked lower level of MMP-2 activity, indicating that Akt1 is important for the expression of MMP-2 in VSMCs.

Figure 2
Akt1 regulates growth factor mediated dorsal ruffle formation, and Rac1 and MMP-2 activity in VSMC

Loss of Akt1 leads to a reduction in PAK1 phosphorylation without changing p38 and ERK signalling pathways

In order to directly examine cellular substrate that may explain the impaired migratory response in VSMC, we studied Akt substrate phosphorylation (PAK, FoxO1, GSK3β and MDM2) after PDGF stimulation. As shown in Fig. 3a, quantified in the right panels of 3b, all substrates were basally phosphorylated on their respective Akt phosphorylation sites. The loss of Akt1 markedly reduced the phosphorylation of PAK1 and total-Akt, but not FoxO1, GSK3 and MDM2. In addition, absence of Akt1 did not affect the phosphorylation levels of ERK and p38 and the total PDGFR expression (Fig. 3).

Figure 3
Substrate specificity of Akt1 in VSMC

Absence of Akt1 reduces VSMC survival and the loss of Akt1 in vivo induces features of plaque vulnerability and acute myocardial infarction

To investigate whether Akt1 is important for regulating VSMC viability, we analysed VSMC survival after treatment with H2O2 (as an apoptogen) using double staining (propidium iodide/ annexin V) analysis by flow cytometry. As shown in Fig. 4a, and quantified in Fig. 4b, the absence of Akt1 causes a dramatic increase of annexin V positive cells, indicating that this Akt isoform is crucial for sustaining VSMC survival. Similar results were obtained when we determined viable and apoptotic cells by their hypochromic, subdiploid staining profile (subG1 population) after incubation of WT and Akt1−/− VSMC in absence of serum at different time points (Fig. 4c).

Figure 4
Akt1−/− VSMC show increased susceptibility to apoptosis by oxidative stress and serum starvation

VSMC apoptosis has been implicated in a number of deleterious consequences in atherosclerosis, including plaque rupture, vessel remodelling, coagulation, inflammation and calcification 4, 21. In advanced plaques, the fibrous cap is thinned from loss of VSMC, and thin-cap fibroatheromatas are the most prevalent lesions that rupture to produce fatal heart attacks 6. We recently showed that mice deficient in Akt1 in an ApoE null background exhibit enhanced atherosclerosis 14, however the role of Akt1 on plaque morphology remains unknown. To assess the potential role of Akt1 on plaque composition, we subjected double knockout ApoE−/−Akt1−/− and corresponding ApoE−/− mice to high cholesterol diet for 14 weeks and analyzed the aortic root lesion areas by hematoxylin/eosin (cellular composition) and Masson’s trichrome (collagen composition) staining. In ApoE−/−, plaques contained a thick VSMC-rich fibrous cap with abundant collagen and matrix overlying small necrotic cores (Fig. 5a). However, fibrous caps were markedly thinner in ApoE−/−Akt1−/− mice, with smaller cap areas per plaque area and displayed reduced collagen composition (Fig. 5a). Moreover, in mice lacking Akt1 necrotic core areas (NC) were markedly larger (Fig. 5a).

Figure 5
Absence of Akt1 induces feature of atherosclerotic plaque vulnerability and cardiac dysfunction in mice

Impaired cardiac function and myocardial infarcts in mice lacking Akt1

Previously we found that ApoE−/−Akt1−/− mice have coronary occlusions and approximately 20% of the mice die spontaneously14. Similar findings were reporting coronary lesions were found in ApoE-deficient mice maintained on chow diet for 10 months 22, 23, 24. To determine if coronary artery disease may have contributed to cardiac performance, we performed echocardiographic studies in both groups of mice. As seen in Fig. 5b, 42% percent of the ApoE−/−Akt1−/− double knockout mice analyzed had increased left ventricular systolic diameter (LVSd) and reduced fractional shortening consistent with a reduction in contractile function. The reduction in contractibility was independent of changes in left ventricular diastolic diameter (LVDd), posterior wall thickness (PWT) and interventricular wall septal thickness (IVWS) (data not shown). Further analysis showed that all the mice with contractile dysfunction showed a dramatic interstitial fibrosis and distal coronary atherosclerosis as revealed by Masson’s trichrome staining of heart sections (Supplemental Figure I) and obvious spontaneous infarcts as showed after TTC staining (Fig. 5c, representative image observed in 2 additional mice with cardiac dysfunction and not observed in all mice with normal cardiac function).

DISCUSSION

Our study provides in vitro and in vivo data supporting a critical role for Akt1 in regulating proliferation, survival and migration of VSMC and its implication in atherosclerotic plaque formation. Lack of Akt1 in VSMC causes a reduction in proliferation, PDGF-induced migration and increased apoptosis after serum starvation and oxidative stress. Mechanistically, the proliferative and migratory phenotype found in Akt1 null VSMCs was linked to a reduced Rac-1 activation and MMP-2 expression and secretion. The importance of Akt1 for proliferation and migration has previously been reported in different cell types 17. The absence of Akt1 causes impaired integrin activation, migration, and formation of actin-based structures such as membrane ruffles in ECs and fibroblast. Similarly, we show that loss of Akt1 in VSMC results in impaired cell migration, Rac activation and PDGF-induce dorsal ruffle formation. These results identify Akt1 as the key Akt isoform in regulating VSMC proliferation, migration and cell survival.

Akt is a multifunctional kinase implicated in a broad range of cellular functions including survival 10. We previously demonstrated that Akt1 is critical in sustaining EC and monocyte/macrophage survival 14. Since VSMC apoptosis has important implications in atherosclerosis and is responsible for promoting plaque stability in advanced lesions 4, we studied the potential role of this Akt isoform in cell death. VSMC lacking Akt1 were more susceptible to apoptosis after treatment with H2O2 (as an apoptogen) or serum starvation. The potential role of Akt signaling pathway on VSMC survival has also been explored in cells derived from human atherosclerotic lesions 25. Plaque derived VSMC showed increased sensitivity to proapoptotic stimuli and reduced insulin-like growth factor 1 receptor (IGF1R)/Akt signaling. Moreover, Allard et al demonstrated that Akt-dependent phosphorylation and subsequent inactivation of FoxoO3a and GSK3 were important for VSMC survival 25. Similarly, we described here reduced GSK3 phosphorylation in response to PDGF in VSMC lacking Akt1.

VSMC apoptosis alone in mouse models is sufficient to induce multiple features of atherosclerotic plaque vulnerability including reduced VSMC content, thin fibrous caps, as well as increased plaque lipid content and necrotic cores compared to stable lesions 4. Here, we found that the absence of Akt1 increases necrotic cores and reduces collagen content and fibrous cap thickness in atherosclerotic plaques from ApoE/Akt1 deficient mice. The increased necrotic core observed in this animal model could also be due to an increase in macrophage apoptosis as we previously described 14. In agreement with this idea is that insulin-resistant macrophages have reduced Akt activity, and are more susceptible to endoplasmic reticulum stress-associated apoptosis contributing to macrophage death and necrotic core formation in atherosclerotic plaques 26, 27. Collectively, these data suggest that the absence of Akt1 in VSMC and macrophages increases the apoptotic susceptibility of these cells in vivo and may lead to a dramatic increase in necrotic core formation in atherosclerotic plaques. We also showed that absence of Akt1 in vivo causes a significant reduction in collagen content and fibrous cap thickness which correlates with the reduced growth and increased apoptosis found in VSMC lacking Akt1.

In humans, plaques with advanced necrotic cores are responsible for acute atherothrombotic events 28. We previously reported that global absence of Akt1 leads to severe atherosclerosis, coronary artery disease and significant mortality (20%) in the doubly mutant mice 14. In the present study using prospective monitoring of cardiac function, approximately 50% of the doubly mutant mice had compromised cardiac function before the end of the high fat diet feeding period. This suggests that the global loss of Akt1 does not influence cardiac function, per se; however, all mice with impaired cardiac function had intramyocardial lesions and infarcts upon sacrifice. Importantly, it is not known why a sub group of ApoE−/−Akt1−/− progress to infarction, while others do not, despite all ApoE−/−Akt1−/− mice having distal coronary lesions (upon sacrifice). Additional studies monitoring electrical changes in the heart during paradigms of cardiac stress (dobutamine challenge or exercise) would be interesting to test the relationship between coronary lesions and cardiac function.

Supplementary Material

supp1

ACKNOWLEDGMENTS

a. Source of funding: This work was supported by grants R01 HL64793, R01 HL61371, R01 HL57665, P01 Hl70295 and Contract No. N01-HV-28186 (NHLBI-Yale Proteomics Contract) from the National Institutes of Health to W.C. Sessa, and by a Scientist Development Grant from American Heart Association to C. Fernández-Hernando. L. József is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research. b. Acknowledgements- The authors would like to acknowledge the generosity of Dr. Howard Rockman for assistance with echocardiographic training and measurements. c. There are no disclosures.

REFERENCES

1. Glass CK, Witztum JL. Atherosclerosis. the road ahead. Cell. 2001;104(4):503–516. [PubMed]
2. Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–874. [PubMed]
3. Lusis AJ. Atherosclerosis. Nature. 2000;407(6801):233–241. [PMC free article] [PubMed]
4. Clarke MC, Figg N, Maguire JJ, Davenport AP, Goddard M, Littlewood TD, Bennett MR. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med. 2006;12(9):1075–1080. [PubMed]
5. Littlewood TD, Bennett MR. Apoptotic cell death in atherosclerosis. Curr Opin Lipidol. 2003;14(5):469–475. [PubMed]
6. Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. Am J Pathol. 1995;147(2):251–266. [PMC free article] [PubMed]
7. Lutgens E, Daemen MJ, de Muinck ED, Debets J, Leenders P, Smits JF. Chronic myocardial infarction in the mouse: cardiac structural and functional changes. Cardiovasc Res. 1999;41(3):586–593. [PubMed]
8. Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296(5573):1655–1657. [PubMed]
9. Whiteman EL, Cho H, Birnbaum MJ. Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab. 2002;13(10):444–451. [PubMed]
10. Fayard E, Tintignac LA, Baudry A, Hemmings BA. Protein kinase B/Akt at a glance. J Cell Sci. 2005;118(Pt 24):5675–5678. [PubMed]
11. Ackah E, Yu J, Zoellner S, Iwakiri Y, Skurk C, Shibata R, Ouchi N, Easton RM, Galasso G, Birnbaum MJ, Walsh K, Sessa WC. Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis. J Clin Invest. 2005;115(8):2119–2127. [PMC free article] [PubMed]
12. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, Walsh K. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest. 2005;115(8):2108–2118. [PMC free article] [PubMed]
13. Somanath PR, Razorenova OV, Chen J, Byzova TV. Akt1 in endothelial cell and angiogenesis. Cell Cycle. 2006;5(5):512–518. [PMC free article] [PubMed]
14. Fernandez-Hernando C, Ackah E, Yu J, Suarez Y, Murata T, Iwakiri Y, Prendergast J, Miao RQ, Birnbaum MJ, Sessa WC. Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab. 2007;6(6):446–457. [PMC free article] [PubMed]
15. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem. 2001;276(42):38349–38352. [PubMed]
16. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2(5):358–367. [PubMed]
17. Somanath PR, Byzova TV. 14-3-3beta-Rac1-p21 activated kinase signaling regulates Akt1-mediated cytoskeletal organization, lamellipodia formation and fibronectin matrix assembly. J Cell Physiol. 2009;218(2):394–404. [PMC free article] [PubMed]
18. Uzui H, Lee JD, Shimizu H, Tsutani H, Ueda T. The role of protein-tyrosine phosphorylation and gelatinase production in the migration and proliferation of smooth muscle cells. Atherosclerosis. 2000;149(1):51–59. [PubMed]
19. Pauly RR, Passaniti A, Bilato C, Monticone R, Cheng L, Papadopoulos N, Gluzband YA, Smith L, Weinstein C, Lakatta EG, et al. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res. 1994;75(1):41–54. [PubMed]
20. Risinger GM, Jr, Hunt TS, Updike DL, Bullen EC, Howard EW. Matrix metalloproteinase-2 expression by vascular smooth muscle cells is mediated by both stimulatory and inhibitory signals in response to growth factors. J Biol Chem. 2006;281(36):25915–25925. [PubMed]
21. Bennett MR. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc Res. 1999;41(2):361–368. [PubMed]
22. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994;14(1):133–140. [PubMed]
23. Reddick RL, Zhang SH, Maeda N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb. 1994;14(1):141–147. [PubMed]
24. Hu W, Polinsky P, Sadoun E, Rosenfeld ME, Schwartz SM. Atherosclerotic lesions in the common coronary arteries of ApoE knockout mice. Cardiovasc Pathol. 2005;14(3):120–125. [PubMed]
25. Allard D, Figg N, Bennett MR, Littlewood TD. Akt regulates the survival of vascular smooth muscle cells via inhibition of FoxO3a and GSK3. J Biol Chem. 2008;283(28):19739–19747. [PubMed]
26. Han S, Liang CP, DeVries-Seimon T, Ranalletta M, Welch CL, Collins-Fletcher K, Accili D, Tabas I, Tall AR. Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. Cell Metab. 2006;3(4):257–266. [PubMed]
27. Senokuchi T, Liang CP, Seimon TA, Han S, Matsumoto M, Banks AS, Paik JH, DePinho RA, Accili D, Tabas I, Tall AR. Forkhead transcription factors (FoxOs) promote apoptosis of insulin-resistant macrophages during cholesterol-induced endoplasmic reticulum stress. Diabetes. 2008;57(11):2967–2976. [PMC free article] [PubMed]
28. Myoishi M, Hao H, Minamino T, Watanabe K, Nishihira K, Hatakeyama K, Asada Y, Okada K, Ishibashi-Ueda H, Gabbiani G, Bochaton-Piallat ML, Mochizuki N, Kitakaze M. Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome. Circulation. 2007;116(11):1226–1233. [PubMed]
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • EST
    EST
    Published EST sequences
  • Gene
    Gene
    Gene links
  • GEO Profiles
    GEO Profiles
    Related GEO records
  • HomoloGene
    HomoloGene
    HomoloGene links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...